From: Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
Stimuli | MSC source | Model/disease | In vitro/in vivo | Results | References |
---|---|---|---|---|---|
3D cell culture in collagen-hydrogel scaffold | Umbilical Cord | – | In vitro | Induced chondrogenesis differentiation by increasing expressions of collagen II, aggrecan, COMPS. | [118] |
3D cell culture in chitosan scaffold | Bone marrow (rat) | – | In vitro | Induced chondrogenesis differentiation by increased production of collagen type II. | [119] |
3D cell culture of composite combining an affinity peptide sequence (E7) and hydrogel | Bone marrow (rat) | – | In vitro | Increased cell survival, matrix production, and improved chondrogenic differentiation ability. | [120] |
3D cell culture of alginate/chondroitin sulfate | Bone marrow | – | In vitro | Induced type II collagen synthesis and chondrogenesis in the scaffolds. | [104] |
3D cell culture of collagen/hydroxyapatite, hydroxyapatite, and biphasic calcium phosphate | Bone marrow (rat) | – | In vitro | Exhibited the highest osteogenic capacity in collagen/hydroxyapatite, but the poorest in hydroxyapatite. | [123] |
3D cell culture in poly(ethylene glycol)-variant scaffolds | Bone marrow | – | In vitro | Upregulated osteogenic markers and osteocalcin expression. | [125] |
3D cell culture of mineralized collagen sponges and alpha-tricalcium phosphate (alpha-TCP) | Bone marrow | – | In vitro | Improved seeding efficacy and increased osteogenic marker genes (mineralized collagen scaffold). | [126] |
3D cell culture in hydrogel | Bone marrow (murine) | Excisional wound healing model | In vitro/in vivo (mice) | Induced angiogenic cytokines and expression of Oct4, Sox2, Klf4 in vitro and enhanced wound healing in vivo. | [129] |
Encapsulation in hydrogel | Bone marrow (rat) | Diabetic ulcers model | In vitro/In vivo (rats) | Promoted granulation tissue formation, angiogenesis, extracellular matrix secretion, wound contraction, and re-epithelialization. | [130] |
Glucose concentration in the culture medium | Telomerase-immortalized (hMSC-TERT) | – | In vitro | High-glucose concentration (25 mM) increased proliferation and osteogenic differentiation. | [132] |
High glucose concentration in the culture medium | Bone marrow | Â | In vitro | Decreased chondrogenic capacity. | [133] |
Medium from cardiomyocytes exposed to oxidative stress and high glucose | Bone marrow (diabetic mouse) | Diabetes induced with streptozotocin model | In vitro/in vivo (mice) | Enhanced survival, proliferation and angiogenic ability, increased the ability to improve function in a diabetic heart. | [134] |
Spheroid formation (different techniques) | Bone marrow | Â | In vitro | Enhanced homogenous cellular aggregates formation and improved osteogenic differentiation (low attachment plates). | [139] |
Spheroids formation (hanging-drop) | Bone marrow | Zymosan-induced peritonitis model | In vitro/in vivo (mice) | Expressed high levels of anti-inflammatory (TSG-6 and STC-1) and anti-tumorigenic molecules compared to 2D culture, suppressed inflammation in vivo. | [140] |
Spheroid formation (chitosan films) | Adipose tissue | Cutaneous wound model | In vitro/in vivo (mice) | Increased expansion efficiency with less senescence and enhanced migration; improved healing and enhanced angiogenesis in the wounds. | [142] |
Spheroids formation (hanging drop) | Cord blood | Hindlimb ischemia model | In vitro/in vivo (mice) | Improved engraftment; increased the number of microvessels and smooth muscle α-actin-positive vessels. | [143] |